Project cooperationUpdated on 16 January 2026
R&D services in bioprocess development and bioreactors for in vitro screening platforms
Co-development Architect at Antleron
Leuven, Belgium
About
From discovery to process development and CMC, Antleron’s smart scale-down model service combines custom, lab-scale, modular bioreactors with its Nexus-driven digital twin platform to predict, develop and optimize clinical-scale bioprocesses and manufacturing systems. Antleron’s CellGuide® fixed-bed upstream bioreactor platform completes its smart scale-down model offering by enabling improved quality, consistency and scalability from lab to patient for bespoke therapies.
Antleron also developed expertise and technology to facilitate high-throughput screening of materials and implants in a biological environment. The efficient and robust lab-scale testing platform is suitable for testing of a variety of parameters, timing and read-outs. It can be customized to accomodate different types of implants and materials.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Multi & Single Use Bioreactors with Advanced Process Control
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Esther Aguilar
Senior Project Manager at TECNIC Bioprocess Solutions
Riudarenes, Spain
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Paola Castrillo
Innovation Manager at BLUE SYNERGY
Madrid, Spain
Project cooperation
Upscaling cell production - from research to product
- Partner seeks Consortium/Coordinator
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Wouter Beenker
Project Manager / Scientist at Scinus Cell Expansion
Zeist, Netherlands